Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-25T15:13:56.288Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of increasing iron supplementation on blood lipids in rats†

Published online by Cambridge University Press:  09 March 2007

Paul Whittaker  and
Ronald F. Chanderbhan
Paul Whittaker*
Affiliation:
Center for Food Safety and Applied Nutrition, Food and Drug Administration, 200 C Street S.W., HFS-236, Washington, DC 20204, USA
Ronald F. Chanderbhan
Affiliation:
Center for Food Safety and Applied Nutrition, Food and Drug Administration, 200 C Street S.W., HFS-236, Washington, DC 20204, USA
*
*Corresponding author: Dr Paul Whittaker, fax +1 202 260 7036, email paul.whittaker@cfsan.fda.gov
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The effects of increasing levels of Fe on serum fatty acids, cholesterol, triacylglycerol, liver and heart were examined in male Sprague–Dawley rats fed either Fe-deficient or carbonyl Fe-supplemented diets with 35 (control), 350, 3500 and 20 000 μg Fe/g for 12 weeks. As intake of Fe increased, serum total cholesterol increased from 2·0 mmol/l in controls to 5·2 mmol/l at the highest level of Fe. Also, the total serum phospholipid fatty acids increased from 609 mg/dl in controls to 1292 mg/l at the highest level of Fe. Except for the highest dose of Fe, the ratio of saturated to unsaturated phospholipid fatty acids increased from 1·2 to 1·7. The serum total free fatty acid levels remained constant among all groups with a range from 162 to 228 mg/l, while a ratio of 0·6 to 0·8 for saturated to unsaturated fatty acids was maintained. A dose-related increase in liver non-haem Fe from 18 to 3500 μg/g correlated with increases in lipid peroxidation (r 0·87), measured by the lipid-conjugated diene assay. Oxidative changes in the liver may have resulted in alterations in sterol synthesis, leading to increased serum cholesterol levels with increases in serum phospholipids and changes in the ratios of their saturated to unsaturated fatty acids. Animals with heart damage showed myocardial degeneration and cardiomyopathy with haemosiderin in interstitial macrophages or myocardial fibres and, when these were coupled with the findings of increased non-haem Fe in the heart and lipid peroxidation in the liver, suggested that oxidative stress is involved in the pathogenesis of the lesions.

Keywords

IronLipidsLipid peroxidationCardiotoxicityRats
Type
Research Article
Information
British Journal of Nutrition , Volume 86 , Issue 5 , November 2001 , pp. 587 - 592
Copyright
Copyright © The Nutrition Society 2001

Footnotes

†

The studies reported herein were conducted according to the principles set forth in the Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, National Research Council, National Academy Press, Washington, DC, 1996. The mention of trade names, commercial products, or organizations does not imply endorsement by the US Food and Drug Administration.

References

Referenses

ABstat (1993) Abstat User Manual, Version 6.04. Parker, CO: Anderson–Bell.Google Scholar
Ascherio, A, Walter, CW, Rimm, EB, Giovannucci, EL & Stampfer, MJ (1994) Dietary iron intake and risk of coronary disease among men. Circulation 89, 969–974.Google Scholar
Baer, DM, Tekawa, IS & Hurley, LB (1994) Iron stores are not associated with acute myocardial infarction. Circulation 89, 2915–2918.CrossRefGoogle Scholar
Brunet, S, Thibault, L, Delvin, E, Yotov, W, Bendayan, M & Levy, E (1999) Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats. Hepatology 29, 1809–1817.CrossRefGoogle ScholarPubMed
Burkitt, MJ & Mason, RP (1991) Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload. Proceedings of the National Academy of Sciences USA 88, 8440–8444.CrossRefGoogle ScholarPubMed
Dabbagh, AJ, Mannion, TS, Lynch, M & Frei, B (1994) The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochemical Journal 300, 799–803.Google Scholar
Finch, CA (1959) Body iron exchange in man. Journal of Clinical Investigation 38, 392–396.Google Scholar
Finch, CA, Ragan, HA, Dyer, IA & Cook, JD (1978) Body iron loss in animals. Proceedings of the Society for Experimental Biology and Medicine 159, 335–338.Google Scholar
Folch, J, Lees, M & Sloane Stanley, GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. Journal of Biological Chemistry 226, 497–509.Google Scholar
Foretz, M, Foufelle, F & Ferré, P (1999) Polyunsaturated fatty acids inhibit fatty acid synthase and spot-14-protein gene expression in cultured rat hepatocytes by a peroxidative mechanism. Biochemistry Journal 341, 371–376.Google Scholar
Kiechl, S, Aichner, F, Gerstenbrand, F, Egger, G, Mair, A, Rungger, G, Spogler, F, Jarosch, E, Oberhollenzer, F & Willeit, J (1994) Body iron stores and presence of carotid atherosclerosis: results from the Bruneck study. Arteriosclerosis and Thrombosis 14, 1625–1630.CrossRefGoogle ScholarPubMed
Kiechl, S, Willeit, J, Egger, G, Poewe, W & Oberhollenzer, F (1997) Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96, 3300–3307.Google Scholar
Klipstein-Grobusch, K, Koster, JF, Grobbee, DE, Lindemans, J, Boeing, H, Hofman, A & Witteman, JCM (1999) Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam study. American Journal of Clinical Nutrition 69, 1231–1236.CrossRefGoogle ScholarPubMed
Lauffer, RB (1991) Iron stores and the international variation in mortality from coronary artery disease. Medical Hypotheses 1991, 96–102.Google Scholar
Liao, Y, Cooper, RS & McGee, DL (1994) Iron status and coronary heart disease: negative findings from NHANES 1 epidemiologic follow-up study. American Journal of Epidemiology 139, 704–712.CrossRefGoogle Scholar
Luna, LG (1968) Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. 3rd ed. New York: McGraw-Hill.Google Scholar
Lynch, SM & Frei, B (1993) Mechanisms of copper-and iron-dependent oxidative modification of human low density lipoprotein. Journal of Lipid Research 34, 1745–1753.Google Scholar
Magnusson, MK, Sigfusson, N, Sigvaldason, H, Johannesson, GM, Magnusson, S & Thorgeirsson, G (1994) Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89, 102–108.CrossRefGoogle ScholarPubMed
Morrison, WR & Smith, LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron trifluoride-methanol. Journal of Lipid Research 5, 600–608.Google Scholar
Olson, LJ, Edwards, WD, McCall, JT, Ilstrup, DM & Gersh, BJ (1987) Cardiac iron deposition in idiopathic hemochromatosis: Histologic and analytic assessment of 14 hearts from autopsy. Journal of the American College of Cardiology 10, 1239–1243.Google Scholar
Powell, LW, Isselbacher, KJ, (1987) Hemochromatosis. In Harrison's Principles of Internal Medicine, 11th ed., pp.1632–1635 [Braunwald, E, Isselbacher, KJ, Peterdorf, RG, Wilson, JD, Martin, JB and Fauci, AS, editors]. New York: McGraw-Hill.Google Scholar
Rasmussen, ML, Folsom, AR, Catellier, DJ, Tsai, MY, Garg, U & Eckfeldt, JH (2001) A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 154, 739–746.Google Scholar
Reunanen, A, Takkunen, H, Knekt, P, Seppanen, R & Aromaa, A (1995) Body iron stores, dietary iron intake and coronary heart disease mortality. Journal of Internal Medicine 238, 223–230.Google Scholar
Salonen, JT, Nyyssönen, K, Kirpela, H, Tuomilehto, J, Seppänen, R & Salonen, R (1992) High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 86, 803–811.Google Scholar
Schwartz, CJ, Valente, AJ, Sprague, EA, Kelley, JL & Nerem, RM (1991) The pathogenesis of atherosclerosis: An overview. Clinical Cardiology 14, 1–16.Google Scholar
Sempos, CT, Looker, AC, Gillum, RF & Makuc, DM (1994) Body iron stores and the risk of coronary heart disease. New England Journal of Medicine 330, 1119–1124.Google Scholar
Smith, C, Mitchinson, MJ, Aruoma, OI & Halliwell, B (1992) Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochemical Journal 286, 901–905.Google Scholar
Snedecor, GW & Cochran, WG (1980) Statistical Methods, 7th ed., pp. 175–193, 215–237. Ames, IA: The lowa State University Press.Google Scholar
Stevens, RG, Graubard, BI, Micozzi, MS, Neriishi, K & Blumberg, BS (1994) Moderate elevation of body iron level and increased risk of cancer occurrence and death. International Journal of Cancer 56, 364–369.Google Scholar
Thompson, SW & Hunt, RD (1966) Selected Histochemical and Histopathological Methods. Springfield, IL: Charles c. Thomas.Google Scholar
Watson, BD, Busto, R, Goldberg, WJ, Santiso, M, Yoshida, S & Ginsberg, MD (1984) Lipid peroxidation in in vivo induced by reversible global ischemia in rat brain. Journal of Neurochemistry 42, 268–274.CrossRefGoogle ScholarPubMed
Whittaker, P, Hines, FA, Robl, MG & Dunkel, VC (1996 a) Histopathological evaluation of liver, pancreas, spleen, and heart from iron-overloaded Sprague–Dawley rats. Toxicologic Pathology 24, 558–563.Google Scholar
Whittaker, P, Skikne, BS, Covell, AM, Flowers, C, Cooke, A, Lynch, SR & Cook, JD (1989) Duodenal iron proteins in idiopathic hemochromatosis. Journal of Clinical Investigation 83, 261–267.Google Scholar
Whittaker, P, Wamer, W & Calvert, RJ (1992) Effect of chronic iron overload on iron status, lipid peroxidation, cell proliferation, and DNA damage. Journal of Trace Element and Experimental Medicine 5, 227–236.Google Scholar
Whittaker, P, Wamer, WG, Chanderbhan, RF & Dunkel, VC (1996) Effects of α-tocopherol and β-carotene on hepatic lipid peroxidation and blood lipids in rats with dietary iron overload. Nutrition and Cancer 25, 119–128.Google Scholar
Williams, RE, Zweier, JL & Flaherty, JT (1991) Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation 83, 1006–1014.CrossRefGoogle ScholarPubMed
Witztum, JL (1994) The oxidation hypothesis of atherosclerosis. Lancet 344, 793–795.Google Scholar